Biogen CEO to step down as the drugmaker plans further Aduhelm cost cuts
Biogen's Chief Executive Officer Michel Vounatsos is stepping down as it is grappling with Medicare restricting coverage for its Alzheimer's drug Aduhelm.
Source link
- ‘We want Ukraine in the European Union,’ Italy’s premier says
- Somalia: Three dead as al-Shabab attacks AU peacekeepers camp